[1]
|
Tan, Z., Sun, H., Xue, T., Gan, C., Liu, H., Xie, Y., et al. (2021) Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy. Frontiers in Cell and Developmental Biology, 9, Article ID: 730176.
https://doi.org/10.3389/fcell.2021.730176
|
[2]
|
Higashi, T., Friedman, S.L. and Hoshida, Y. (2017) Hepatic Stellate Cells as Key Target in Liver Fibrosis. Advanced Drug Delivery Reviews, 121, 27-42. https://doi.org/10.1016/j.addr.2017.05.007
|
[3]
|
Zeng, D.W., Dong, J., Liu, Y.R., Jiang, J.J. and Zhu, Y.Y. (2016) Noninvasive Models for Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B Virus Infection. World Journal of Gastroenterology, 22, 6663-6672.
https://doi.org/10.3748/wjg.v22.i29.6663
|
[4]
|
Bottcher, K. and Pinzani, M. (2017) Pathophysiology of Liver Fi-brosis and the Methodological Barriers to the Development of Anti-Fibrogenic Agents. Advanced Drug Delivery Re-views, 121, 3-8.
https://doi.org/10.1016/j.addr.2017.05.016
|
[5]
|
Lee, Y.A., Wallace, M.C. and Friedman, S.L. (2015) Pathobiology of Liver Fibrosis: A Translational Success Story. Gut, 64, 830-841. https://doi.org/10.1136/gutjnl-2014-306842
|
[6]
|
Campana, L. and Iredale, J.P. (2017) Regression of Liver Fibro-sis. Seminars in Liver Disease, 37, 1-10.
https://doi.org/10.1055/s-0036-1597816
|
[7]
|
Tsuchida, T. and Friedman, S.L. (2017) Mechanisms of Hepatic Stel-late Cell Activation. Nature Reviews Gastroenterology & Hepatology, 14, 397-411. https://doi.org/10.1038/nrgastro.2017.38
|
[8]
|
Marrone, G., Shah, V.H. and Gracia-Sancho, J. (2016) Sinusoidal Communication in Liver Fibrosis and Regeneration. Journal of Hepatology, 65, 608-617. https://doi.org/10.1016/j.jhep.2016.04.018
|
[9]
|
Friedman, S.L. (2008) Hepatic Stellate Cells: Protean, Multifunc-tional, and Enigmatic Cells of the Liver. Physiological Reviews, 88, 125-172. https://doi.org/10.1152/physrev.00013.2007
|
[10]
|
Van Grunsven, L.A. (2017) 3D in Vitro Models of Liver Fibro-sis. Advanced Drug Delivery Reviews, 121, 133-146.
https://doi.org/10.1016/j.addr.2017.07.004
|
[11]
|
Trivedi, P., Wang, S. and Friedman, S.L. (2021) The Power of Plasticity—Metabolic Regulation of Hepatic Stellate Cells. Cell Metabolism, 33, 242-257. https://doi.org/10.1016/j.cmet.2020.10.026
|
[12]
|
Huisman, T.M., Dieterich, D.T. and Friedman, S.L. (2021) Ex-perimental and Investigational Targeted therapies for the Management of Fibrosis in NASH: An Update. Journal of Ex-perimental Pharmacology, 13, 329-338.
https://doi.org/10.2147/JEP.S265286
|
[13]
|
Kisseleva, T. and Brenner, D. (2021) Molecular and Cellular Mecha-nisms of Liver Fibrosis and Its Regression. Nature Reviews Gastroenterology & Hepatology, 18, 151-166. https://doi.org/10.1038/s41575-020-00372-7
|
[14]
|
De Smet, V., Eysackers, N., Merens, V., Kazemzadeh Dastjerd, M., Halder, G., Verhulst, S., et al. (2021) Initiation of hepatic stellate cell activation extends into chronic liver disease. Cell Death & Disease, 12, Article No. 1110.
https://doi.org/10.1038/s41419-021-04377-1
|
[15]
|
Peng, Y. and Croce, C.M. (2016) The Role of MicroRNAs in Humancancer. Signal Transduction and Targeted Therapy, 1, Article ID: 15004. https://doi.org/10.1038/sigtrans.2015.4
|
[16]
|
Hyun, J., Wang, S., Kim, J., Rao, K.M., Park, S.Y., Chung, I., et al. (2016) MicroRNA-378 Limits Activation of Hepatic Stellate Cells and Liver Fibrosis by Suppressing Gli3 Expression. Nature Communications, 7, Article No. 10993.
https://doi.org/10.1038/ncomms10993
|
[17]
|
Ma, L., Yang, X., Wei, R., Ye, T., Zhou, J.K., Wen, M., et al. (2018) MicroRNA-214 Promotes Hepatic Stellate Cell Activation and Liver Fibrosis by Suppressing Sufu Expression. Cell Death & Disease, 9, Article No. 718.
https://doi.org/10.1038/s41419-018-0752-1
|
[18]
|
Zheng, J., Wu, C., Xu, Z., Xia, P., Dong, P., Chen, B., et al. (2015) Hepatic Stellate Cell Is Activated by MicroRNA-181b via PTEN/Akt Pathway. Molecular and Cellular Biochem-istry, 398, 1-9.
https://doi.org/10.1007/s11010-014-2199-8
|
[19]
|
Yang, X., Ma, L., Wei, R., Ye, T., Zhou, J., Wen, M., et al. (2020) Twist1-Induced miR-199a-3p Promotes Liver Fibrosis by Suppressing Caveolin-2 and Activating TGF-β Path-way. Signal Transduction and Targeted Therapy, 5, Article No. 75. https://doi.org/10.1038/s41392-020-0169-z
|
[20]
|
徐静, 严永敏, 蔡梦洁. miR-373下调转化生长因子βⅡ型受体表达抑制肝星状细胞活化[J]. 中国组织工程研究, 2022, 26(5): 756-761.
|
[21]
|
Gao, J., Wei, B., de Assuncao, T.M., Liu, Z., Hu, X., Ibrahim, S., et al. (2020) Hepatic Stellate Cell Autophagy Attenuates Liver Fibrosis by Inhibiting Extra-cellular Vesicle Release. Journal of Hepatology, 73, 1144-1154.
https://doi.org/10.1016/j.jhep.2020.04.044
|
[22]
|
钱南南, 唐露露, 魏涛华, 杨悦, 郝文杰, 杨文明. 外泌体非编码RNA在肝纤维化中的作用及机制[J]. 临床肝胆病杂志, 2021, 37(10): 2429-2434.
|
[23]
|
Patop, I.L., Wüst, S. and Kadener, S. (2019) Past, Present, and Future of CircRNAs. The EMBO Journal, 38, Article ID: e100836. https://doi.org/10.15252/embj.2018100836
|
[24]
|
Sanger, H.L., Klotz, G., Riesner, D., Gross, H.J. and Klein-schmidt, A.K. (1976) Viroids Are Single-Stranded Covalently Closed Circular RNA Molecules Existing as Highly Base-Paired Rod-Like Structures. Proceedings of the National Academy of Sciences of the United States of America, 73, 3852-3856. https://doi.org/10.1073/pnas.73.11.3852
|
[25]
|
Jin, J., Sun, H., Shi, C., Yang, H., Wu, Y., Li, W., et al. (2020) Circular RNA in Renal Diseases. Journal of Cellular and Molecular Medicine, 24, 6523-6533. https://doi.org/10.1111/jcmm.15295
|
[26]
|
Du, W.W., Zhang, C., Yang, W., Yong, T., Awan, F.M. and Yang, B.B. (2017) Identifying and Characterizing CircRNA- Protein Interaction. Theranostics, 7, 4183-4191. https://doi.org/10.7150/thno.21299
|
[27]
|
Yao, W., Li, Y., Han, L., Ji, X., Pan, H., Liu, Y., et al. (2018) The CDR1as/miR-7/TGFBR2 Axis Modulates EMT in Silica-Induced Pulmonary Fibrosis. Toxicological Sciences, 166, 465-478. https://doi.org/10.1093/toxsci/kfy221
|
[28]
|
Liu, W., Feng, R., Li, X., Li, D. and Zhai, W. (2019) TGF-β- and Lipopolysaccharide-Induced Upregulation of Circular RNA PWWP2A Promotes Hepatic Fibrosis via Sponging miR-203 and miR-223. Aging, 11, 9569-9580.
https://doi.org/10.18632/aging.102405
|
[29]
|
Ji, D., Chen, G.F., Wang, J.C., Ji, S.H., Wu, X.W., Lu, X.J., et al. (2020) Hsa_circ_0070963 Inhibits Liver Fibrosis via Regulation of miR-223-3p and LEMD3. Aging, 12, 1643-1655. https://doi.org/10.18632/aging.102705
|
[30]
|
Ralf, W., Sabine, W. and Frank, T. (2019) Organ and Tissue Fibrosis: Molecular Signals, Cellular Mechanisms and Translational Implications. Molecular Aspects of Medicine, 65, 2-15. https://doi.org/10.1016/j.mam.2018.06.003
|
[31]
|
Li, S., Song, F., Lei, X., Li, J., Li, F. and Tan, H. (2020) hsa_circ_0004018 Suppresses the Progression of Liver Fibrosis through Regulating the hsa-miR-660-3p/TEP1 Axis. Aging, 12, 11517-11529.
https://doi.org/10.18632/aging.103257
|
[32]
|
Chen, X., Li, H.D., Bu, F.T., Li, X.F., Chen, Y., Zhu, S., et al. (2020) Circular RNA CircFBXW4 Suppresses Hepatic Fibrosis via Targeting the miR-18b-3p/FBXW7 Axis. Theranostics, 10, 4851-4870. https://doi.org/10.7150/thno.42423
|
[33]
|
Czuba, L.C., Wu, X., Huang, W., Hollingshead, N., Roberto, J.B., Kenerson, H.L., et al. (2021) Altered Vitamin A Metabolism in Human Liver Slices Corresponds to Fibrogenesis. Clinical and Translational Science, 14, 976-989.
https://doi.org/10.1111/cts.12962
|
[34]
|
Blaner, W.S., Li, Y., Brun, P.J., Yuen, J.J., Lee, S.A. and Clugston, R.D. (2016) Vitamin A Absorption, Storage and Mobilization. In: Asson-Batres, M. and Rochette-Egly, C., Eds., The Bio-chemistry of Retinoid Signaling II, Springer, Dordrecht, 95-125. https://doi.org/10.1007/978-94-024-0945-1_4
|
[35]
|
Kanki, K., Akechi, Y., Ueda, C., Tsuchiya, H., Shimizu, H., Ishijima, N., et al. (2013) Biological and Clinical Implications of Retinoic Acid-Responsive Genes in Human Hepatocel-lular Carcinoma Cells. Journal of Hepatology, 59, 1037- 1044. https://doi.org/10.1016/j.jhep.2013.06.024
|
[36]
|
Shimizu, H., Tsubota, T., Kanki, K. and Shiota, G. (2018) All-Trans Retinoic Acid Ameliorates Hepatic Stellate Cell Activation via Suppression of Thioredoxin Interacting Protein Expression. Journal of Cellular Physiology, 233, 607- 616. https://doi.org/10.1002/jcp.25921
|